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Abstract
Septins (SEPTs) form a family of GTP-binding proteins implicated in cytoskeleton and membrane organization, cell division
and host/pathogen interactions. The precise function of many family members remains elusive. We show that SEPT6 and
SEPT7 complexes bound to F-actin regulate protein sorting during multivesicular body (MVB) biogenesis. These complexes
bind AP-3, an adapter complex sorting cargos destined to remain in outer membranes of maturing endosomes, modulate
AP-3 membrane interactions and the motility of AP-3-positive endosomes. These SEPT-AP interactions also influence the
membrane interaction of ESCRT (endosomal-sorting complex required for transport)-I, which selects ubiquitinated cargos
for degradation inside MVBs. Whereas our findings demonstrate that SEPT6 and SEPT7 function in the spatial, temporal
organization of AP-3- and ESCRT-coated membrane domains, they uncover an unsuspected coordination of these sorting
machineries during MVB biogenesis. This requires the E3 ubiquitin ligase LRSAM1, an AP-3 interactor regulating ESCRT-I
sorting activity and whose mutations are linked with Charcot-Marie-Tooth neuropathies.
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Introduction
Septins (SEPTs) comprise a family of GTP-binding proteins that
assemble into oligomers and form higher-order structures in vitro
[1,2]. In mammalian cells, SEPTs have been implicated in
multiple cellular processes [3,4], including cytoskeleton organiza-
tion by binding to F-actin [5] or microtubules [6,7]. In polarized
cells, SEPT2 facilitates post-Golgi vesicle transport to the plasma
membrane by maintaining poly-Glu microtubules [8] and forms a
diffusion barrier at the base of the ciliary membrane [9,10]. In
neurons SEPT3 and SEPT5 are required for synaptic vesicle
fusion and recycling [11]. During phagocytosis of pathogens,
SEPT2 or SEPT9 mediates caging of bacteria to counteract
pathogen dissemination [12,13].
After endocytosis, transmembrane proteins are sorted in early
endosomes to different destinations, either back to the cell surface
or to the trans-Golgi network (TGN) or to late endocytic
compartments for degradation. Transport from early to late
endosomes is a complex membrane maturation process involving
the formation of multivesicular bodies (MVBs). During this
process, transmembrane cargos destined to remain in the outer
membrane of late endocytic compartments such as lysosome
membrane proteins (LAMPs) are segregated away from cargos
destined for degradation inside maturing early endosomes.
The ESCRT complex (comprising ESCRT-0, I, II and III
subcomplexes) segregates ubiquinated cargos destined for degra-
dation into vesicles budding inside maturating early endosomes
[14,15,16,17,18]. The sorting of cargos destined to remain in the
outer membrane is less clear. AP-3, one member of the hetero-
tetrameric adaptor complexes [19,20], localizes to peripheral early
endosomes [21] and functions in the targeting of cargos destined to
remain in the outer membrane of lysosomes and lysosome-related
organelles [22,23,24,25]. Mutations in AP-3 are linked with
Hermansky-Pudlak syndrome [26]. MVB biogenesis also requires
extensive membrane remodeling, in particular the exchange of the
Rab5 GTPase by Rab7 controlling endosome maturation [27,28].
It also requires membrane binding to cytoskeleton elements, in
particular a switch from F-actin, which maintains early endosomes
in the cell periphery [29] to microtubules needed for MVB
transport to perinuclear late endocytic compartments [30].
Our previous studies identified SEPT6 and SEPT7 and their
effector BORG4, a negative regulator of the Cdc42 GTPase that
controls septin organization [31], among the proteins supporting
AP-3 sorting function [32]. We now illustrate that SEPT6 and
SEPT7 regulate MVB biogenesis by modulating the timely
coordinated interaction of both AP-3 and ESCRT with maturing
early endosomal membranes when bound to F-actin.
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Figure 1. Depletion of SEPT6, SEPT7, BORG4, AP-3m and Rab7 affect transport from early to late endosomes. (A) Hela expressing Gag-
GFP cells were transfected with indicated siRNAs. Culture supernatants (VLP) and cell lysates prepared as described in Materials and Methods
were probed by western blotting with anti GFP and anti LAMP1 antibodies and then quantified (B). Values were normalized to tubulin. The secreted
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Results
SEPT6 and SEPT7 regulate early to late endosome
transport
We previously found that SEPT6, SEPT7 or BORG4 are
involved in the AP-3-dependent, lysosomal targeting of LAMP1, a
protein destined to remind in the outer membrane of late
endosomal compartments [32]. Besides contributing to lysosome
biogenesis, AP-3 has also been implicated in HIV-1 biogenesis
[33]. HIV-1 biogenesis can be examined by the release of the
nucleo-capsid protein Gag into the culture medium of Gag-
expressing cells. We therefore measured the release of Gag virus-
like particles (VLP) from HeLa cells depleted in SEPT6, SEPT7,
BORG4, AP-3 or Rab7 (<80–95% knockdown efficiencies, see
Fig. S1). Fig. 1A, B shows that the depletion of these proteins
inhibited Gag VLP release into the culture medium and also
resulted in a higher LAMP1 stability (i.e. a longer half-life most
likely due to changes in its trafficking) in those cells. Therefore,
SEPT6, SEPT7, BORG4, AP-3 and Rab7 are all required for a
proper HIV-1 Gag and LAMP1 sorting.
EEs are sorting stations from where endocytosed components
are sent to different destinations. Therefore, we investigated
whether these pathways were affected upon SEPT6, SEPT7,
BORG4, AP-3 and Rab7 depletion. We first measured the
recycling of the transferrin receptor back to the cell surface after its
endocytosis. Quantitative image analysis of endocytosed Alexa
Fluor 564-labeled transferrin (referred to as Alexa-transferrin)
(Fig. 1C, Fig. S2C) shows that recycling was mildly affected in
depleted cells. To monitor the retrograde transport of endocytosed
MPR back to the TGN, we took advantage of a HeLa cell line
stably expressing a GFP-tagged version of MPR [34]. Quantitative
image analysis of anti GFP antibodies bound to cell surface GFP-
MPRs and subsequently endocytosed (Fig. S2D) shows that GFP-
MPR recycling back to the TGN was also not affected in depleted
cells (Fig. 1D).
We then monitored the endocytosis and the degradation of
Alexa Fluor 488 EGF (Alexa-EGF) bound to its receptor (EGFR).
In control cells, endocytosed EGF was detected in peripheral EEs
5–10 minutes after internalization, co-localizing with the EEA1
early endosomal marker. It was then concentrated into perinucle-
ar, late endocytic structures (LEs) where it was degraded 30–
60 min after internalization (Fig. 1E, F and Fig. S2A). Quantita-
tive image analysis shows that this transport from EEs to LEs was
remarkably delayed in depleted cells, EGF remaining in EEA1-
positive EEs for longer periods of time (30–60 min) (Fig. 1F, and
Fig. S2B). Similarly, the EGF receptor or its activated form
detected with an antibody against phospho-tyrosine 1068
remained in EEs in depleted cells whereas it was rapidly degraded
in LEs of control cells (Fig. 1G,H and Fig. S3A). Altogether, these
results demonstrate that SEPT6, SEPT7, BORG4 AP-3 and Rab7
regulate transport of cargos from early to late endosomes without
drastically affecting other pathways.
SEPT6 and SEPT7 bound to F-actin regulate the motility
of AP-3-positive endosomes and AP-3 dynamics
Since septin members can bind to F-actin and microtubules, we
examine the precise localization of SEPT6 and SEPT7. Both were
found to colocalize (Fig. 2A), as expected for complexes [35,36]
and to decorate actin filaments (85% of colocalization) (Fig. 2B).
Remarkably, AP-3-positive structures were predominantly detect-
ed along F-actin decorated with SEPT7 (48.9% of AP-3-positive
structures, n = 200) (Fig. 2B). Interestingly, the siRNA-mediated
depletion of Borg4 enhanced SEPT7 binding onto F-actin and the
association of AP-3-coated endosomes (80% of AP-3-positive
structures, n = 200) with F-actin decorated with SEPT7 (Fig. 2C).
These results suggested that SEPT7 mediates the interaction of
AP-3-coated structures with F-actin. Accordingly, the immuno-
precipitation of AP-3 from detergent-solubilized HeLa cell extracts
co-immunoprecipitated significant amounts of SEPT7, thus
indicating interactions between AP-3 and SEPT7 (Fig. 2E). This
prompted us to follow the dynamics of AP-3-positive structures in
live cells. Video microscopy performed on HeLa cells expressing
GFP-tagged AP-3d and mCherry-tagged SEPT7 showed that AP-
3-positive structures were immobile when bound to SEPT7
filaments, then detached moving over short distances before
binding again the SETP7 filaments (Fig. 3 A, movie S1). Similar
observations were made using mCherry-tagged SEPT6 or lifeact-
mRFP, visualizing F-actin (Fig. 3A, movies S2, S3). This dynamic
was drastically affected upon SEPT6 or SEPT7 depletion (movies
S4, S5 and S6). Although the statistical analysis of time-lapse series
indicated that the total number of motile AP-3-positive objects was
not altered in control or depleted cells (not shown), it indicated
that AP-3-positive objects moved along longer tracks in depleted
cells when compared to control cells (Fig. 3A, upper panels,
movies S4, S5, S6) with the very same speed (<1 mm/sec) as seen
in control cells. We also followed the dynamic association of GFP-
AP-3 with endocytic compartments containing internalized Alexa-
EGF using video microscopy. Two events could be observed: the
recruitment of GFP-AP3 onto Alexa-EGF-positive EEs and the
fusion of GFP-AP-3-positive structures with Alexa-EGF-positive
structures. Quantitative image analysis of both events showed that
a maximum co-localization (<50%) between internalized EGF-
and AP-3-postive organelles occurred 8–12 min after EGF-
internalization and then decreased with time in control cells
(Fig. 3C, movie S7). A more detailed analysis indicated that AP-3
remained associated to EGF-positive structures for about 1 min
(Fig. 3D, E, movie S7), consistent with previous studies [37]. In
SEPT6- or SEPT7-depleted cells, this dynamic was drastically
affected. Image analysis showed that maximal co-localization
between internalized EGF and AP-3 was delayed, occurring more
than 10–15 min after EGF internalization (Fig. 3C, movies S8,
S9). Further analysis showed that AP-3 remained only briefly (20–
30 s) associated with EGF-positive endosomes (Fig. 3D, E, movies
S8, S9). Endosomes containing EGF internalized for 5 min were
also more motile upon SETP6 or SEPT7 depletion (Fig. 3B, lower
GAP-GFP represented 5964, 4661, 1467, 5.763, 9.864.5, 8.265, 1165.8, 21.867, 10.867.6, 1568.9, 1466.5% of the total GAG-GFP. (C) Cell surface
receptor bound Alexa 564-transferrin was endocytosed for the indicated period of time in HeLa cells treated with the indicated siRNAs. Fluorescence
intensities were then quantified. (D) Anti GFP antibodies pre-bound to the cell surface GFP-MPR of GFP-MPR expressing cells treated with the
indicated siRNAs were endocytosed for indicated periods of time as indicated in Materials and Methods. Co-localization between the endocytosed
anti GFP antibody and GFP-MPR was quantified. (E) Cell surface receptor bound Alexa-EGF (green) was endocytosed for the indicated periods of time
in HeLa cells treated with the indicated siRNAs as indicated in Materials and Methods. Fluorescence intensities were quantified. (F) Similarly treated
cells were stained with antibodies against EEA1 and the extent of co-localization of Alexa-EGF with EEA1 was calculated. (G) Cell surface receptor
bound EGF was endocytosed for the indicated periods of time in siRNA-treated HeLa cells. The cells were stained with antibodies against the
activated EGF receptor phosphorylated on Tyr1068 (pEGFR) and EEA1. The fluorescence associated with the pEGFR was quantified. (H) Lysates from
similarly treated cells were probed by western blotting using antibodies against the pEGFR or the total EGF receptor. The values are means6 SD of 3
independent experiments.
doi:10.1371/journal.pone.0109372.g001
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panels). Thus, these experiments show that SEPT6 or SEPT7
depletion enhances the motility of AP-3-positive EEs and also
reduces the dynamic interaction of AP-3 with these structures.
These changes in AP-3 dynamics could explain why AP-3 cargos
are missorted in SEPT6- and SEPT7-depleted cells.
SEPT6 and SEPT7 depletion impacts the association of
ESCRTI-III sub-complexes with endosomes and impairs
MVB biogenesis
The ESCRT complex mediates the sorting of receptor-bound
EGF into intra-luminal vesicles for degradation during MVB
biogenesis. We therefore examined the association of ESCRT sub-
complexes with endosomes in SEPT6, SEPT7 or AP-3 depleted
cells. We first monitored the dynamic association of Hrs
(Hepathocyte growth factor-Regulated tyrosine kinase Substrate)
a subunit of the ESCRT-0 sub-complex [38,39] with endosomes
containing endocytosed Alexa-EGF (Fig. 4A, Fig. S3B). In control
and SEPT6-, SEPT7- or AP-3-depleted cells, Hrs was detected on
endosomes 5 min after EGF internalization and remained
associated with these structures during the next 10–20 min (60–
70% colocalization). This colocalization largely decreased in
control cells after 30 min of EGF internalization, consistent with
EGF degradation. In contrast, Hrs remained associated with
endosomes containing endocytosed EGF in depleted cells, even
1 h after EGF endocytosis. This indicated that ESCRT-0 remains
bound to EEs in the absence of SEPT6, SEPT7 or AP-3. We
therefore monitored the interaction the ESCRT-III subunit
CHMP2B (Vps2) with endosomes containing endocytosed EGF.
Figure 2. SEPT6 and SEPT7 bind F-actin and AP-3-positive structures. HeLa cells stably expressing GFP-SEPT6 (green) were labeled with anti
SEPT7 (red) and anti tubulin (blue) antibodies (A). HeLa cells stably expressing GFP-AP3 (white) were untreated (B) or treated with siRNA targeting
Borg4 (C) and then labeled with anti SEPT7 antibodies (red). F-actin and microtubules were labeled with phalloidin or anti tubulin antibodies (green)
(Bar 10 mm). (D) AP-3 was immunoprecipitated from a HeLa cell extract with anti AP-3 antibodies and the immunoprecipitates were probed by
western blotting using antibodies against AP-3 and SEPT7.
doi:10.1371/journal.pone.0109372.g002
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Figure 3. Depletion of SEPT6, SEPT7 affects the motility of endosomes and the dynamic association of AP-3. (A) Time-lapse video
microscopy of HeLa cells stably expressing GFP-AP-3d and transiently expressing Cherry-SEPT6, Cherry-SEPT7 or mRFP-Lifeact (acquisition: 200 ms/
frame, intervals between frames: 475 ms) (Bar 5 mm). (B) HeLa cells stably expressing GFP-AP-3d were depleted or not from SEPT6 or SEPT7 and
observed by video-microscopy. The upper panels shows examples of trajectories of GFP-AP-3d-positive objects (300 objects per condition). Cell
surface receptor-bound Alexa-EGF was endocytosed for 5 min. in control and SEPT6- or SEPT7-depleted Hela cells and Alexa-EGF-positive objects
were observed by video-microscopy. The lower panels show examples of trajectories (300 objects per condition). (C) Cell surface bound Alexa-EGF
was internalized in GFP-AP-3d expressing HeLa cells depleted or not from SEPT6 or SEPT7 and followed by videomicrosopy. The extend of
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In control cells, ESCRTIII was detected on EGF-rich endosomes
10–20 min after EGF internalization (up to 80% colocalization,
Fig. 4B, Fig. S3C). This extent of colocalization decreased with
time. In contrast, the ESCRT-III was not detected on endosomes
containing endocytosed EGF in SEPT6, SEPT7 or AP-3 depleted
cells. To determine which ESCRT subcomplex was affected, we
examined the distribution of Tsg101, an ESCRT-I subunit.
Quantitative image analysis shows that <60% of Hrs-positive
endosomes contained Tsg101 in control cells (Fig. 4C, D). In
contrast, only <25% of Hrs-positive endosomes contained Tsg101
in depleted cells. Altogether, these results indicate that SEPT6,
SEPT7 or AP-3 depletion impacts the binding of ESCRT-I and
ESCRT-III onto ESCRT-0-positive endosomes suggesting that
the late stages of MVB biogenesis, i.e. formation of intra-luminal
vesicles, are impaired.
To further examine this aspect, we used electron microscopy.
HeLa cells depleted or not in SEPT7 or AP-3 were allowed to take
up horseradish peroxidase (HRP) to label early endocytic
structures. In control cells, HRP was detected in typical MVBs
containing intraluminal vesicles (Fig. 5A). However, HRP accu-
mulated in tubular elements and enlarged structures almost devoid
of intraluminal vesicles in SEPT7-depleted cells. HRP was also
detected in tubules emanating from enlarged EEs in AP-3-depleted
cells. HeLa cells were also allowed to endocytosed Alexa-EGF.
The examination of immuno-gold-labeled cryosections (Fig. 5B)
indicated that endocytosed Alexa-EGF and low amounts of
LAMP1 were detected in EEs and MVBs in control cells.
However, in SEP7-depleted cells Alexa-EGF was detected in
unusually enlarged structures devoid of internal vesicles and
frequently found at the cell periphery, as also seen in Hrs-depleted
cells [39]. The quantification of these experiments shows that
SEPT7-depleted HeLa cells significantly accumulated more
enlarged structures than control cells (Table 1). A 3 fold increase
in LAMP1 labeling compared to controls was also detected in
these structures. In AP-3 depleted cells, the morphology of EEs
was also affected, exhibiting long tubular extensions rich in
LAMP1, emanating from large vesicular structures almost devoid
of intraluminal vesicles (Table 1), as also seen in AP-3-deficient
melanocytes of patients with Hemandsky-Pudlack syndrom type II
[40]. These results indicate that the late stages of MVB biogenesis
are affected in SEPT7-depleted cells and more mildly in AP3-
depleted cells.
The E3 ubiquitin ligase LRSAM1 coordinates AP-3 and
ESCRT sorting functions
We previously reconstituted the preferred binding of AP-3 on
PI-3P-rich synthetic membranes [32] and identified by mass
spectrometry LRSAM1 (leucine rich repeats and alpha sterile
alpha motif containing 1) (unpublished observation), an E3
ubiquitin ligase known to ubiquitinate Tsg101, an ESCRT-I
subunit [41]. LRSAM1 was found to localize better with AP-3
(80% of co-localization) than with ESCRT-I (50% of co-
localization with Tsg101) (Fig. 4E,G). LRSAM1 was also found
to be an AP-3 interactor as it co-immunoprecipitated with AP-3
(Fig. 4F). LRSAM1 depletion significantly delayed EGF degrada-
tion (Fig. 1E and Fig. S4), a finding, which contrasts previous
findings based on over-expression [41]. Accordingly, only <35%
of Hrs (ESCRT-0)-positive structures contained Tsg101 (ESCRT-
I) in LRSAM1-depleted cells whereas <60% of Hrs-positive
structures contained Tsg101 in control cells (Fig. 4C, D). Thus,
LRSAM1 likely coordinates AP-3 and ESCRT-I sorting functions.
Discussion
Our study demonstrates the fundamental importance of SEPT6
and SEPT7 complexes bound to F-actin during MVB biogenesis.
By interacting with membrane-bound AP-3, they regulate the
motility of AP-3-positive early endosomes in the cell periphery
while modulating the temporal interaction of AP-3 with these
structures. They also influence the membrane association of
ESCRT sub-complexes during membrane maturation, a process
involving the AP-3 interacting E3 ubiquitin ligase LRSAM1.
Thus, our study reveals an unsuspected coordination between AP-
3 sorting membrane proteins destined to remain in outer
membranes of MVBs, and ESCRT sorting ubiquitinated mem-
brane proteins into intraluminal vesicles for subsequent degrada-
tion (Fig. 5C).
Early endosomes (EEs) bind to and move along F-actin at the
cell periphery [29]. The biological significance of such interactions
remains unclear. Earlier studies have shown that actin polymer-
ization inhibitors prevents the transport beyond early endosomes
and leads to the formation of large vesicles, most likely unable to
maturate into MVBs [42,43]. It has been proposed that the non-
processive Myosin 1B could anchor early endosomes onto F-actin
[42] and that actin patches on early endosomes nucleated via
Annexin2 and Spire1 control early endosome maturation [43]. We
show that SEPT6 and SEPT7 bound to F-actin restrict the motility
of AP-3-positive EEs at the cell periphery and influence the
binding activity of AP-3 onto these structures. Remarkably,, AP-3
coats become less stable on EEs in their absence, an observation
that could easily explain why Lamp1 is missorted to the cell surface
in SEPT6 or SEPT7-depleted cells as previously observed in AP-3-
deficient cells [23,24,25]. This also raises the question of how
SEPT binding to F-actin could influence AP-3 binding onto
membranes. Cdc42 most likely regulates SEPT6 and SETP7
binding onto F-actin as indicated by the implication of Borg4, a
negative regulator of Cdc42 that control septin organization in
AP-3-dependent transport. On another hand, ARF-1 regulates
AP-3 binding onto membranes [44]. Therefore, one may postulate
that proteins able to regulate both Cdc42 and ARF-1 activities
could be involved in this particular aspect. The SEPT6/SEPT7
could exhibit addition roles in F-actin organization. It was recently
reported that SEPT7 bundles F-actin filaments and induce their
curvature at contractile rings during cytokenesis in drosophila
[45].
Our study indicates that SEPT6 and SEPT7 also regulate the
binding activity of ESCRT sub-complexes, which drive the sorting
of ubiquitinated cargos into intraluminal vesicles during MVB
biogenesis [15,18]. We show that, in the absence of SEPT6 and
SEPT7 ESCRT-0-positive endosomes are unable to recruit
ESCRT-I and ESCRT-III to promote the formation of vesicles
budding inside maturing EEs. AP-3 and ESCRT organize
different membrane domains and determine their fate. However,
our study indicates that AP-3 and ESCRT sorting functions are
linked, a process that implicates the E3 ubiquitin ligase LRSAM1,
an AP-3 interactor modulating ESCRT-I sorting function. This
could provide a mechanism for a timed maturation of distinct
membrane domains during this step of endocytic membrane
traffic. Other E3 ubiquitin ligases have been involved in this
colocalization between GFP-AP-3 and Alexa-EGF was estimated. (D) The interaction of GFP-AP-3 with individual Alexa-EGF-positive structures was
recorded and quantified (25 structures per condition) (E). The values are means 6 SD of 3 independent experiments.
doi:10.1371/journal.pone.0109372.g003
Septin6 and Septin7 Regulate Multivesicular Body Biogenesis
PLOS ONE | www.plosone.org 6 November 2014 | Volume 9 | Issue 11 | e109372
process [18]. Therefore, the precise function of LRSAM1 remains
to be fully elucidated in this specific context. It is possible that AP-
3-bound LRSAM1 ubiquitinates specific cargos and/or modulates
an ubiquitin-dependent ESCRT-I sorting activity. Previous studies
reported that the overexpression of a LRSAM1 negative mutant
LRSAM1 accelerates EGF transport and degradation [41]
whereas our study shows that LRSAM1 depletion decreases
EGF transport and degradation. This discrepancy can probably be
Figure 4. Depletion of SEPT6, SEPT7 affects the dynamic association of ESCRT sub-complexes. (A) Cell surface receptor-bound Alexa-EGF
was endocytosed for the indicated periods of time in HeLa cells treated with the indicated siRNAs. Cells were then stained with anti Hrs antibodies.
Extent of colocalization between Alexa-EGF and Hrs was quantified. (B) Similarly treated cells were stained with anti CHMP2B (Vps 2), an ESCRT-III
subunit. Extent of colocalization between Alexa-EGF and ESCRTIII was determined. (C) Control and siRNA treated HeLa cells were stained with
antibodies against Hrs and Tsg101. (D) The extent of colocalization between Hrs and Tsg101 was quantified. (E) Co-localization of LRSAM1 with
Tsg101 and AP-3 and quantification (G). (F) AP-3 was immunuprecipitated from HeLa cell extracts with anti AP-3d antibodies. The
immunoprecipitates were probed by western blotting using antibodies against AP-3d and LRSAM1. The values are means 6 SD of at least 3
independent experiments.
doi:10.1371/journal.pone.0109372.g004
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explained by the methodology used (over-expression of dominant
negative mutant versus gene silencing). Interestingly, mutations in
LRSAM1 are linked with Charcot-Marie-Tooth neurophathies
[46], so are mutations in enzymes regaling PI(3,5)P2 levels ([47,48]
and references therein) or in Rab7 {BasuRay, 2013 #104]. The
Rab7-dependent maturation of EEs into MVBs also requires their
interaction with microtubules [30], a process implicating the
Huntington-HAP40 complex [49]. More recently, SETP6 and
SETP7 have been proposed to connect F-actin and microtubule
remodeling during axon branching [50]. It is therefore possible
that the interaction of AP-3-coated endosomes with SEPT6 and
SEPT7 bound to F-actin may also facilitate a switch from F-actin
to microtubules during MVB biogenesis.
Our previous proteomic screens [32] identified a number of
proteins associated with AP-3 that could coordinate both the
interaction of SEPT6 or SEPT7 with F-actin and that of AP-3
with membranes or could regulate a switch from F-actin to
Figure 5. Morphology of early endosomes in SEPT7 and AP-3 depleted cells. (A) HeLa cells depleted or not in SEPT7 or AP-3 were allowed
to fluid phase endocytose HRP for 7 min and then processed for HRP detection. (B). Similarly, HeLa cells were allowed to internalize for 7 min Alexa-
EGF pre-bound to its cell surface receptors. Cryosections were labeled with primary antibodies against LAMP1, Alexa and secondary antibodies
(LAMP-1, 10 nm gold; Alexa-EGF, 15 nm gold, arrows, Bars 200 nm). (C) Model of SEPT6 and SEPT7 function in MVB biogenesis.
doi:10.1371/journal.pone.0109372.g005
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microtubules during MVB biogenesis. Their function can now be
tested in the light of our current findings.
Materials and Methods
Antibodies and reagents
The following antibodies were used: mouse monoclonal
antibodies against human Lysosomal-associated membrane pro-
tein 1 (LAMP1) (BD Biosience), Septin6 (Abcam, UK), AP-3d
(DSHB), b-Tubulin (Sigma, Germany), Early endosome antigen 1
(EEA1) (BD Biosciences), rabbit polyclonal antibodies against
human Septin 7 (Sigma, Germany), BORG4 (Bethyl Laboratories,
INC), GFP (Roche, Zuerich), Phosphotyrosine1068-EGF Recep-
tor (NBG,Germany), Hrs, Tsg101 (Genetex, Germany), LRSAM1
(Atlas, Sweden). Alexa Fluor 488, 546 or 647 labeled secondary
antibodies against the above-mentioned primary antibodies
(Molecular Probes, Invitrogen, Germany); (HRP)-conjugated goat
anti-mouse IgG and goat anti-rabbit IgG (Jackson ImmunoR-
esearch Laboratories, UK). Phaloidin, Latrunculin B and
Nocodazole were from Calbiochem (CA).
Cell Culture, RNA interference and transfection
HeLa cells (ATCC, USA Cell Bank, UK) and HeLa cells stably
expressing a GFP-tagged MPR (34) were maintained in DMEM
supplemented with 10% fetal calf serum (FCS) and 1% Penicillin/
Streptomycin (Invitrogen, Hamburg). HeLa cells stably expressing
GFP-AP3d were generated as follows. Cells were transfected with
1 mg of GFP-AP-3d containing plasmid. Two days after transfec-
tion, cells were selected in medium supplemented with 0.8 mg/ml
G418 (Gibco, Germany). After 2–3 weeks, single colonies were
picked and transferred into 24-well plates. Clones were analyzed
for expression by fluorescence microscopy and suitable clones were
selected. For the knockdown of target genes, cells were incubated
for 72 h with 20 nM siRNAs and Interferin transfection reagent
(PeqLab, Erlangen) as recommended. Knockdown efficiencies
were evaluated by western blot when antibodies were available or
by quantitative polymerase chain reaction (QPCR) using Brilliant
SYBR Green QPCR Master Mix and Mx400 QPCR System
(Stratagen, Zuerich) (Figure S1). Knockdown efficiencies for
SEPT6, SEPT7, AP-3, BORG4 and Rab7 were around 95%.
The knockdown of one of these genes did not affect the expression
of the others (Figure S1).
The siRNAs were purchased from Dharmacon Research
(Chikago, IL). The following sequences (59 -39) were used: Septin
6 (gaagagtgctacacaccta; cgatatagctcgccaggtg), Septin 7 (ttgcagctgt-
gacttataa, attaagatactcttcctggac). The following siRNA were from
Ambion (Foster City, CA): AP-3m (gctcccaggtaccaaaaagTT,
ggaattacagtgacagttcTT) BORG4 (cccttgattcagaccatggTT; ggaa-
taggttttcctctgtTT) Rab7 (gcaatcagtacaaagccacTT, gctgactttctgac-
caaggTT), nontargeting control (Sinone 5). LRSAM1 (ggttcta-
gatctccacgatTT, caacggcttttgaaccagaTT).
Primer used for QPCR: BORG4-2f (gtccaggaagttccgggg),
BORG4-2r (tcgaggagggggtcaggg), BORG4-3f (gtccatcatgtccttcca-
catc), BORG4-3r (ccggaaggcagggctgcg), Sept6-2f (ccagccacccaca-
cacagccg), Sept6-2r (ccttactgtccagcttcttc), Sept6-3f (gactttgt-
gaagctgcggg), Sept6-3r (tggtgcagtttcttcagacgg), Lrsam1-f
(tgtccataacccaggaggag), Lrsam1-r (atcaacggcttttgaaccag).
Analysis of HIV-1-Gag Release
HeLa cells grown in a 6 cm plate were transfected for 42 h with
different siRNA duplexes as described above. Cells were then
transfected with 6 mg GAG-GFP containing vector (pEGF-n1-gag)
and jetPAI reagent (PeqLab, Erlangen). The cells were incubated
for 24 h and supernatant was collected, clarified by centrifugation.
Membrane particles containing GAG were pelleted through
ultracenrifigation in 20% sucrose layer at 60 000 rpm for 1 h
and resuspended in 26Laemli sample buffer. Cells were washed
with PBS and lysed with 1% Triton X-100 containing protease
inhibitor. GAG-GFP were detected by Western blot with anti GFP
antibodies. For cell imaging, cells grown on coverslips were fixed
with 2% PFA, permeabilized with 0.1% Triton X-100 for 5 min
on ice and blocked with 3% bovine serum albumin for 30 min at
RT. The cells were incubated with primary antibodies against
EEA1 or LAMP1 for 1 h at RT. After washing, cells then
incubated with Alexa Fluor-labeled secondary antibodies for
30 min at RT and then mounted in Mowiol.
Assays for trafficking pathways
The HeLa cells grown on coverslips were treated with siRNAs
for 72 h. They were incubated for 30 min on ice with DMEM
containing 1% bovine serum albumin and 3 mg/ml EGF Alexa
Fluor 488 (Molecular Probes, Germany) or 1 mg/ml Alexa Fluor
564-labeled transferrin (Molecular Probes, Germany). Cells were
washed with phosphate buffered saline (PBS) and incubated at
37uC for 5, 10, 20, 30 and 60 min in DMEM containing 0.5%
FCS. Cells were fixed with 3% paraformaldehyde for 15 min at
RT, permeabilized with 0.1% Triton X-100 for 5 min on ice and
blocked with 3% bovine serum albumin for 30 min at RT. The
cells were incubated with primary antibodies against EEA1 or
LAMP1 or Hrs for 1 h at RT, followed by incubation with Alexa
Fluor-labeled secondary antibodies for 30 min at RT and then
mounted in Mowiol. HeLa cells stably expressing MPR-GFP were
treated as previously described with siRNAs and incubated with
DMEM with 1% BSA and 1 mg/ml anti GFP antibodies for
30 min on ice. Cells were then washed and incubated at 37uC for
5,10,20,30 and 60 min in DMEM with 0.5% BSA. After the
incubation times cells were fixed, permeabilized and blocked as
previously described. The internalized anti GFP antibodies were
detected with Alexa Fluor 546 secondary antibodies. Samples
were analyzed by confocal fluorescence microscopy, using a
confocal laser scanning microscope LSM 510 meta (Carl Zeiss
Table 1. Quantification of MVBs and enlarged endosomes in control, SEPT7- or AP-3-depleted HeLa cells.
MVBs (%) Enlarged endosomes (%)
Control cells 3468 1067
SEPT7-depleted cells 2366 1565
AP3-depleted cells 2466 2266
HeLa cells were incubated with HRP for 7 min. and processed for electron microscopy as indicated in Materials and Methods. The labeled structures were identified as
endosomal structures (vesicular and lamellar), typical MVBs and enlarged endosomes. The values 6 SD represent the percentage of the indicated structures in 3
independent experiments.
doi:10.1371/journal.pone.0109372.t001
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Microimaging, Germany) and a 1006, 1.4 plan apochromat
objective (Carl Zeiss Microimaging). Images were analyzed using
Fiji software (http://rsb.info.nih.gov/ij/) or CellProfiler software.
Anova Single Factor (Excel) was used for statistical image analyses.
Live-cell imaging and quantitative analysis of vesicle
dynamics
HeLa cells stably expressing GFP-AP-3d were used. Cells were
treated with siRNAs as described above. They were also
transfected as described above with mCherry-Septin7 or
mCherry-Septin6 or pEGFP-c1-Septin6 or mRFP-Life Act
plasmids. To follow the dynamic interaction of AP-3 with
endocytosed Alexa-EGF, HeLa cells stably expressing GFP-AP-3
were allow to bind exogenously added Alexa-EGF on ice as
described above and the cells were then washed and warmed up at
37uC and then imaged by time lapse videomicroscopy. For the live
imaging, Leica AFLX6000 TIRF (with Leica HCX PL APO
10061.40-0.70 Oil objectives) was used at a controlled temper-
ature, CO2 and humidity.
GFP-AP-3-positive or Alexa-EGF-containing object trajectories
were generated by wavelet segmentation and global tracking based
on distance and intensity using MIA [51] was performed for all
acquisition series of 600 frames. A preprocessing photobleaching
correction by intensity normalization was applied to help tracking
association. A coated object was considered not to move between
two frames if its displacement was inferior to 3 pixels (1
pixel = 143 nm; time between two frames = 154 ms; then displace-
ment of 1 pixel/frame= 0.93 mm/s), due to the resolution of its
centroid identification. In order to exclude false tracks, only
tracking trajectories of more than 5 consecutive time frames over
all 600 frame series, were considered.
Imunoprecipitation of AP-3
HeLa cells were extracted with lysis buffer (10 mM HEPES
pH 7.4, 150 mM NaCl, 1 mM EGTA, 0.1 mM MgCl2, 0.5%
Triton X-100) containing a complete antiprotease coktail (Roche,
Penzberg). 1 mg of the cell extract proteins was incubated at 4uC
for two hours with AP-3d antibodies coupled to Sepharose beads.
The beads were washed 4 times with lysis Buffer+0.1% Triton-100
and incubated with Laemli sample Buffer at 90uC for 5 min.
Immunoprecipitates were analyzed by Western Blot using anti AP-
3d, anti SEPT7 or anti LRSAM1 antibodies.
Electron Microscopy
For ultrathin cryosectioning and immunogold labeling, control
and siRNA inactivated cells were allowed to internalize cell
surface-bound EGF-Alexa (4 mm/ml) for 7 min. Cells were
washed at 4uC, then fixed with a mixture of 2% PFA and 0.2%
glutaraldehyde in 0.1 M phosphate buffer, pH 7.4. Cells were
processed for ultracryomicrotomy and single or double immuno-
gold labeled with the indicated antibodies detected using Protein A
conjugated to gold (PAG10 or PAG15; purchased from Cell
Microscopy Center, Utrecht, The Netherlands) as reported [52].
For HRP cytochemistry and conventional Electron Microscopy,
control and inactivated HeLa cells grown on coverslips were
grown in serum free media and allowed to internalize Horse
Radish Peroxidase (HRP) (10 mg/ml, Sigma, Germany) for 7 min
at 37uC. After washing at 4uC, cells were fixed with a mixture of
PFA 2% and Glutaraldeyde 1.5%. Cells were washed with
Cacodylate buffer 0.2M and further rinsed in Tris-HCl pH 7.6
before incubation with di-aminobenzidine and H2O2 for 20 min.
Cells were further fixed with 2.5% glutaraldehyde in 0.1M
cacodylate buffer for 24 h and processed as described previously
[53]. All samples were analyzed using a FEI CM120 electron
microscope (FEI Company) at 80 kV, and digital acquisitions were
made with a numeric camera (Keen View; Soft Imaging System,
SIS, Germany).
Supporting Information
Figure S1 Efficiencies of siRNA-mediated depletions of AP-3m,
SEPT6, SEPT7, LRSAM1 and Rab7. (A) The knockdown
efficiencies of the indicated siRNAs were determined by qPCR
as indicated in Materials and Methods. Values are means 6 SD of
at least 3 independent experiments. The knockdown efficiencies
were confirmed by western blotting as exemplified for Borg4 (B),
SEPT6 (C) and SEPT7 (D).
(TIF)
Figure S2 Endocytosis of EGF, Transferrin and GFP-MPR. In
this series of experiments, only examples are provided for control,
SEPT7- and AP-3-depleted cells. The quantification of these
experiments is presented in Fig. 1. HeLa cells grown on cover slips
were treated with siRNAs targeting SEPT6, SEPT7, BORG4, AP-
3m, Rab7 or control siRNAs. Cells were then processed as follows:
(A) Endocytosis of EGF: HeLa cells treated with the indicated
siRNAs were incubated on ice for 30 min with 5 mg/ml Alexa-
EGF (green) and then incubated at 37uC for the indicated periods
of time. Cells were fixed, stained with DAPI (Blue). The total
fluorescence intensity of EGF-labeled objects associated per cell
was then quantified. (Bars: 20 mm) (B) Fixed cells were also stained
with antibodies against the endosomal marker EEA1 (red) and
then processed for microscopy. (Bars: 10 mm). (C) Recycling of
endocytosed transferrin: the treated HeLa cells were incubated on
ice for 30 min with 1 mg/ml fluorescent transferrin and then
incubated at 37uC for the indicated periods of time. Cells were
fixed, stained with DAPI (Blue) and then processed for
microscopy, (Bar: 20 mm). (D) Recycling of endocytosed GFP-
MPR: Stably expressing GFP-MPR HeLa cells grown on cover
slips were treated with siRNAs as above. The cells were incubated
on ice for 30 min with exogenously added anti GFP antibodies
and then incubated at 37uC for the indicated periods of time. Cells
were fixed, stained with DAPI (Blue) and secondary antibodies
against IgGs (Red), (Bar: 20 mm).
(TIF)
Figure S3 Activation of EGF receptor and interaction of
ESCRT-0 and ESCRT-III with endosomes during EGF endocy-
tosis. (A) Endocytosis of EGF-Receptor: HeLa cells were treated
with siRNAs targeting SEPT6, SEPT7, BORG4, AP-3m, Rab7 or
control siRNAs. The cells were incubated on ice for 30 min with
5 mg/ml EGF and then incubated at 37uC for 15 min and 45 min.
Cells were fixed, stained with DAPI (Blue) and antibodies against
the activate form of the EGF receptor (EGFR phosphorylated on
Tyr 1068, red) and the endosomal marker EEA1 (green) and then
processed for microscopy (Bars 10 mm). The quantification of
these experiments is presented in Fig. 1G. (B, C) Binding of Hrs
(ESCRT-0) and CHMP2B (ESCRT-III) to endosomes containing
endocytosed Alexa-EGF: HeLa cells were treated with siRNAs
targeting SEPT6, SEPT7, AP-3m or control siRNAs. (B). The cells
were incubated on ice for 30 min with 5 mg/ml Alexa-EGF (Red)
and then incubated at 37uC for the indicated periods of time. Cells
were fixed, stained with DAPI (Blue) and antibodies against Hrs
(Green) and then processed for microscopy. (C) Control and
treated cells were also incubated on ice for 30 min with Alexa-
EGF (Green) and then incubated at 37uC for the indicated periods
of time. Cells were fixed, stained with DAPI (Blue) and antibodies
against anti CHMP2B (Red). Merge images are presented (Bars
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10 mm). The quantification of these experiments is presented in
Fig. 4A, B.
(TIF)
Figure S4 EGF endocytosis in LRSAM1 depleted cells. HeLa
cells were treated with control or siRNAs targeting LRSAM1. The
cells were incubated on ice for 30 min with 5 mg/ml Alexa-EGF
(Red) and then incubated at 37uC for the indicated periods of
time. Cells were fixed, stained with DAPI (Blue) and then
processed for microscopy. The quantification of these experiments
are presented in Figure 1E.
(TIF)
Movie S1 Dynamics of GFP-AP-3-positive objects along Cher-
ry-SEPT7 filaments (Bars 10 mm).
(AVI)
Movie S2 Dynamics of GFP-AP-3-positive objects along Cher-
ry-SEPT6 filaments (Bars 10 mm).
(AVI)
Movie S3 Dynamics of GFP-AP-3-positive objects along mRFP-
Lifeact filaments (Bars 10 mm).
(AVI)
Movie S4 Dynamics of GFP-AP-3-positive objects in control
cells. The last frame of the movie represents the compilation of all
frames (Bars 10 mm).
(MOV)
Movie S5 Dynamics of GFP-AP-3-positive objects in SEPT6-
depleted cells. The last frame of the movie represents the
compilation of all frames (Bars 10 mm).
(MOV)
Movie S6 Dynamics of GFP-AP-3-positive objects in SEPT7-
depleted cells. The last frame represents a compilation of all
frames (Bars 10 mm).
(MOV)
Movie S7 GFP-AP-3 dynamics during endocytosis of Alexa-
EGF in control cells (Bars 10 mm).
(AVI)
Movie S8 GFP-AP-3 dynamics during endocytosis of Alexa-
EGF in SEPT6-depleted cells (Bars 10 mm).
(AVI)
Movie S9 GFP-AP-3 dynamics during endocytosis of Alexa-
EGF in SEPT7-depleted cells (Bars 10 mm).
(AVI)
Acknowledgments
We thank the different lab members for their helpful discussions and
critical comments.
Author Contributions
Conceived and designed the experiments: BH ST. Performed the
experiments: ST CS GR. Analyzed the data: ST PPG JS GR. Contributed
reagents/materials/analysis tools: ST CS TW. Wrote the paper: BH ST.
References
1. Kinoshita M (2006) Diversity of septin scaffolds. Curr Opin Cell Biol 18: 54–60.
2. Barral Y, Kinoshita M (2008) Structural insights shed light onto septin
assemblies and function. Curr Opin Cell Biol 20: 12–18.
3. Saarikangas J, Barral Y (2011) The emerging functions of septins in metazoans.
EMBO Rep 12: 1118–1126.
4. Spiliotis ET, Gladfelter AS (2012) Spatial guidance of cell asymmetry: septin
GTPases show the way. Traffic 13: 195–203.
5. Kremer BE, Adang LA, Macara IG (2007) Septins regulate actin organization
and cell-cycle arrest through nuclear accumulation of NCK mediated by
SOCS7. Cell 130: 837–850.
6. Surka MC, Tsang CW, Trimble WS (2002) The mammalian septin MSF
localizes with microtubules and is required for completion of cytokinesis. Mol
Biol Cell 13: 3532–3545.
7. Nagata K, Kawajiri A, Matsui S, Takagishi M, Shiromizu T, et al. (2003)
Filament formation of MSF-A, a mammalian septin, in human mammary
epithelial cells depends on interactions with microtubules. J Biol Chem 278:
18538–18543.
8. Spiliotis ET, Hunt SJ, Hu Q, Kinoshita M, Nelson WJ (2008) Epithelial polarity
requires septin coupling of vesicle transport to polyglutamylated microtubules.
J Cell Biol 180: 295–303.
9. Hu Q, Milenkovic L, Jin H, Scott MP, Nachury MV, et al. (2010) A septin
diffusion barrier at the base of the primary cilium maintains ciliary membrane
protein distribution. Science 329: 436–439.
10. Chih B, Liu P, Chinn Y, Chalouni C, Komuves LG, et al. (2012) A ciliopathy
complex at the transition zone protects the cilia as a privileged membrane
domain. Nat Cell Biol 14: 61–72.
11. Tsang CW, Fedchyshyn M, Harrison J, Xie H, Xue J, et al. (2008) Superfluous
role of mammalian septins 3 and 5 in neuronal development and synaptic
transmission. Mol Cell Biol 28: 7012–7029.
12. Mostowy S, Cossart P (2011) Autophagy and the cytoskeleton: new links
revealed by intracellular pathogens. Autophagy 7: 780–782.
13. Mostowy S, Cossart P (2012) Septins: the fourth component of the cytoskeleton.
Nat Rev Mol Cell Biol 13: 183–194.
14. Rusten TE, Vaccari T, Stenmark H (2012) Shaping development with ESCRTs.
Nat Cell Biol 14: 38–45.
15. Hanson PI, Cashikar A (2012) Multivesicular body morphogenesis. Annu Rev
Cell Dev Biol 28: 337–362.
16. Henne WM, Buchkovich NJ, Emr SD (2011) The ESCRT pathway. Dev Cell
21: 77–91.
17. Piper RC, Katzmann DJ (2007) Biogenesis and function of multivesicular bodies.
Annu Rev Cell Dev Biol 23: 519–547.
18. Katzmann DJ, Odorizzi G, Emr SD (2002) Receptor downregulation and
multivesicular-body sorting. Nat Rev Mol Cell Biol 3: 893–905.
19. Owen DJ, Collins BM, Evans PR (2004) Adaptors for clathrin coats: structure
and function. Annu Rev Cell Dev Biol 20: 153–191.
20. Edeling MA, Smith C, Owen D (2006) Life of a clathrin coat: insights from
clathrin and AP structures. Nat Rev Mol Cell Biol 7: 32–44.
21. Peden AA, Oorschot V, Hesser BA, Austin CD, Scheller RH, et al. (2004)
Localization of the AP-3 adaptor complex defines a novel endosomal exit site for
lysosomal membrane proteins. J Cell Biol 164: 1065–1076.
22. Cowles CR, Odorizzi G, Payne GS, Emr SD (1997) The AP-3 adaptor complex
is essential for cargo-selective transport to the yeast vacuole. Cell 91: 109–118.
23. Le Borgne R, Alconada A, Bauer U, Hoflack B (1998) The mammalian AP-3
adaptor-like complex mediates the intracellular transport of lysosomal
membrane glycoproteins. J Biol Chem 273: 29451–29461.
24. Dell’Angelica EC, Shotelersuk V, Aguilar RC, Gahl WA, Bonifacino JS (1999)
Altered trafficking of lysosomal proteins in Hermansky-Pudlak syndrome due to
mutations in the beta 3A subunit of the AP-3 adaptor. Mol Cell 3: 11–21.
25. Feng L, Seymour AB, Jiang S, To A, Peden AA, et al. (1999) The beta3A
subunit gene (Ap3b1) of the AP-3 adaptor complex is altered in the mouse
hypopigmentation mutant pearl, a model for Hermansky-Pudlak syndrome and
night blindness. Hum Mol Genet 8: 323–330.
26. Dell’Angelica EC (2009) AP-3-dependent trafficking and disease: the first
decade. Curr Opin Cell Biol 21: 552–559.
27. Rink J, Ghigo E, Kalaidzidis Y, Zerial M (2005) Rab conversion as a mechanism
of progression from early to late endosomes. Cell 122: 735–749.
28. Press B, Feng Y, Hoflack B, Wandinger-Ness A (1998) Mutant Rab7 causes the
accumulation of cathepsin D and cation-independent mannose 6-phosphate
receptor in an early endocytic compartment. J Cell Biol 140: 1075–1089.
29. Gasman S, Kalaidzidis Y, Zerial M (2003) RhoD regulates endosome dynamics
through Diaphanous-related Formin and Src tyrosine kinase. Nat Cell Biol 5:
195–204.
30. Aniento F, Emans N, Griffiths G, Gruenberg J (1993) Cytoplasmic dynein-
dependent vesicular transport from early to late endosomes. J Cell Biol 123:
1373–1387.
31. Joberty G, Perlungher RR, Sheffield PJ, Kinoshita M, Noda M, et al. (2001)
Borg proteins control septin organization and are negatively regulated by Cdc42.
Nat Cell Biol 3: 861–866.
32. Baust T, Anitei M, Czupalla C, Parshyna I, Bourel L, et al. (2008) Protein
networks supporting AP-3 function in targeting lysosomal membrane proteins.
Mol Biol Cell 19: 1942–1951.
33. Dong X, Li H, Derdowski A, Ding L, Burnett A, et al. (2005) AP-3 directs the
intracellular trafficking of HIV-1 Gag and plays a key role in particle assembly.
Cell 120: 663–674.
Septin6 and Septin7 Regulate Multivesicular Body Biogenesis
PLOS ONE | www.plosone.org 11 November 2014 | Volume 9 | Issue 11 | e109372
34. Waguri S, Dewitte F, Le Borgne R, Rouille Y, Uchiyama Y, et al. (2003)
Visualization of TGN to endosome trafficking through fluorescently labeled
MPR and AP-1 in living cells. Mol Biol Cell 14: 142–155.
35. Low C, Macara IG (2006) Structural analysis of septin 2, 6, and 7 complexes.
J Biol Chem 281: 30697–30706.
36. Sirajuddin M, Farkasovsky M, Hauer F, Kuhlmann D, Macara IG, et al. (2007)
Structural insight into filament formation by mammalian septins. Nature 449:
311–315.
37. Kural C, Tacheva-Grigorova SK, Boulant S, Cocucci E, Baust T, et al. (2012)
Dynamics of intracellular clathrin/AP1- and clathrin/AP3-containing carriers.
Cell Rep 2: 1111–1119.
38. Raiborg C, Bache KG, Gillooly DJ, Madshus IH, Stang E, et al. (2002) Hrs sorts
ubiquitinated proteins into clathrin-coated microdomains of early endosomes.
Nat Cell Biol 4: 394–398.
39. Bache KG, Brech A, Mehlum A, Stenmark H (2003) Hrs regulates
multivesicular body formation via ESCRT recruitment to endosomes. J Cell
Biol 162: 435–442.
40. Theos AC, Tenza D, Martina JA, Hurbain I, Peden AA, et al. (2005) Functions
of adaptor protein (AP)-3 and AP-1 in tyrosinase sorting from endosomes to
melanosomes. Mol Biol Cell 16: 5356–5372.
41. Amit I, Yakir L, Katz M, Zwang Y, Marmor MD, et al. (2004) Tal, a Tsg101-
specific E3 ubiquitin ligase, regulates receptor endocytosis and retrovirus
budding. Genes Dev 18: 1737–1752.
42. Salas-Cortes L, Ye F, Tenza D, Wilhelm C, Theos A, et al. (2005) Myosin Ib
modulates the morphology and the protein transport within multi-vesicular
sorting endosomes. J Cell Sci 118: 4823–4832.
43. Morel E, Parton RG, Gruenberg J (2009) Annexin A2-dependent polymeriza-
tion of actin mediates endosome biogenesis. Dev Cell 16: 445–457.
44. Ooi CE, Dell’Angelica EC, Bonifacino JS (1998) ADP-Ribosylation factor 1
(ARF1) regulates recruitment of the AP-3 adaptor complex to membranes. J Cell
Biol 142: 391–402.
45. Mavrakis M, Azou-Gros Y, Tsai FC, Alvarado J, Bertin A, et al. (2014) Septins
promote F-actin ring formation by crosslinking actin filaments into curved
bundles. Nat Cell Biol 16: 322–334.
46. Guernsey DL, Jiang H, Bedard K, Evans SC, Ferguson M, et al. (2010)
Mutation in the gene encoding ubiquitin ligase LRSAM1 in patients with
Charcot-Marie-Tooth disease. PLoS Genet 6.
47. Chow CY, Zhang Y, Dowling JJ, Jin N, Adamska M, et al. (2007) Mutation of
FIG4 causes neurodegeneration in the pale tremor mouse and patients with
CMT4J. Nature 448: 68–72.
48. Vaccari I, Dina G, Tronchere H, Kaufman E, Chicanne G, et al. (2011) Genetic
interaction between MTMR2 and FIG4 phospholipid phosphatases involved in
Charcot-Marie-Tooth neuropathies. PLoS Genet 7: e1002319.
49. Pal A, Severin F, Lommer B, Shevchenko A, Zerial M (2006) Huntingtin-
HAP40 complex is a novel Rab5 effector that regulates early endosome motility
and is up-regulated in Huntington’s disease. J Cell Biol 172: 605–618.
50. Hu J, Bai X, Bowen JR, Dolat L, Korobova F, et al. (2012) Septin-driven
coordination of actin and microtubule remodeling regulates the collateral
branching of axons. Curr Biol 22: 1109–1115.
51. Angenieux C, Fraisier V, Maitre B, Racine V, van der Wel N, et al. (2005) The
cellular pathway of CD1e in immature and maturing dendritic cells. Traffic 6:
286–302.
52. Slot JW, Geuze HJ (2007) Cryosectioning and immunolabeling. Nat Protoc 2:
2480–2491.
53. Raposo G, Cordonnier MN, Tenza D, Menichi B, Durrbach A, et al. (1999)
Association of myosin I alpha with endosomes and lysosomes in mammalian
cells. Mol Biol Cell 10: 1477–1494.
Septin6 and Septin7 Regulate Multivesicular Body Biogenesis
PLOS ONE | www.plosone.org 12 November 2014 | Volume 9 | Issue 11 | e109372
